Orchid Pharma Limited Statistics
Want to see IN:ORCHPHARMA full AI Analyst Report?
Orchid Pharma Limited (ORCHPHARMA) Stock Statistics & Valuation Metrics
Total Valuation
Orchid Pharma Limited has a market cap or net worth of INR 55.82B. The enterprise value is INR 26.49B.
- Market Cap
- INR 55.82B
- Enterprise Value
- INR 26.49B
Share Statistics
Orchid Pharma Limited has 59,885,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 59,885,200
- Owned by Insiders
- ―
- Owned by Institutions
- 0.10%
Financial Efficiency
Orchid Pharma Limited’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 0.34%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 0.34%
- Return on Capital Employed (ROCE)
- 0.00
- Revenue Per Employee
- 6.94M
- Profits Per Employee
- 175.77K
- Employee Count
- 1,169
- Asset Turnover
- 0.42
- Inventory Turnover
- 2.55
Valuation Ratios
The current PE Ratio of Orchid Pharma Limited is 544.36. Orchid Pharma Limited’s PEG ratio is -6.06.
- PE Ratio
- 544.36
- PS Ratio
- 5.56
- PB Ratio
- 3.67
- Price to FCF
- -35.59
- Price to Operating Cash Flow
- 410.20
- PEG Ratio
- -6.06
Income Statement
In the last 12 months, Orchid Pharma Limited had revenue of 8.11B and earned 205.47M in profits. Earnings per share was 4.05.
- Revenue
- 8.11B
- Gross Profit
- 1.59B
- Operating Income
- 56.76M
- Pretax Income
- 203.55M
- Net Income
- 205.47M
- EBITDA
- 489.22M
- Earnings Per Share (EPS)
- 4.05
Cash Flow
In the last 12 months, operating cash flow was 115.10M and capital expenditures -1.59B, giving a free cash flow of -1.47B billion.
- Operating Cash Flow
- 115.10M
- Free Cash Flow
- -1.47B
- Free Cash Flow per Share
- -29.03
Dividends & Yields
Orchid Pharma Limited pays an annual dividend of INR 3.00, resulting in a dividend yield of ―
- Dividend Per Share
- INR 3.00
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.04%
- Earnings Yield
- 0.18%
Stock Price Statistics
- Beta
- 1.05
- 52-Week Price Change
- 8.65%
- 50-Day Moving Average
- 946.37
- 200-Day Moving Average
- 821.79
- Relative Strength Index (RSI)
- 55.12
- Average Volume (3m)
- 6,321
Important Dates
Orchid Pharma Limited upcoming earnings date is Feb 11, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 14, 2026
- Next Earnings Date
- Feb 11, 2027
- Ex-Dividend Date
- Sep 13, 2012
Financial Position
Orchid Pharma Limited as a current ratio of 2.45, with Debt / Equity ratio of 28.16%
- Current Ratio
- 2.45
- Quick Ratio
- 1.53
- Debt to Market Cap
- 0.15
- Net Debt to EBITDA
- 7.27
- Interest Coverage Ratio
- 0.43
Taxes
In the past 12 months, Orchid Pharma Limited has paid -1.92M in taxes.
- Income Tax
- -1.92M
- Effective Tax Rate
- -0.01
Enterprise Valuation
Orchid Pharma Limited EV to EBITDA ratio is 96.54, with an EV/FCF ratio of -32.93.
- EV to Sales
- 5.14
- EV to EBITDA
- 96.54
- EV to Free Cash Flow
- -32.93
- EV to Operating Cash Flow
- 421.26
Balance Sheet
Orchid Pharma Limited has INR 832.11M in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 832.11M billion.
- Cash & Marketable Securities
- INR 832.11M
- Total Debt
- INR 0.00
- Net Cash
- INR 832.11M
- Net Cash Per Share
- INR 13.90
- Tangible Book Value Per Share
- INR 253.91
Margins
Gross margin is 25.73%, with operating margin of 4.42%, and net profit margin of 0.92%.
- Gross Margin
- 25.73%
- Operating Margin
- 4.42%
- Pretax Margin
- 1.23%
- Net Profit Margin
- 0.92%
- EBITDA Margin
- 5.33%
- EBIT Margin
- 1.32%
Analyst Forecast
The average price target for Orchid Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.83%
- EPS Growth Forecast
- -89.83%
Scores
- Smart Score
- ―
- AI Score
- 57

